EXCITATION-FUNCTIONS OF PROTON-INDUCED REACTIONS ON COBALT - PRODUCTION OF NO-CARRIER ADDED NI-57, A POSITRON EMITTING LABEL FOR DOXORUBICIN

被引:5
作者
ZWEIT, J
CARNOCHAN, P
GOODALL, R
OTT, RJ
机构
[1] ROYAL MARSDEN HOSP,JOINT DEPT PHYS,SUTTON SM2 5PT,SURREY,ENGLAND
[2] CLATTERBRIDGE CTR ONCOL,DOUGLAS CYCLOTRON UNIT,WIRRAL L63 4JY,ENGLAND
关键词
D O I
10.1016/0969-8043(93)90093-P
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Excitation functions were measured, by the stacked-foil technique, for the Co-59(p, 3n)Ni-57 and Co-59(p, 4n)Ni-56 nuclear reactions from threshold up to 60 MeV. The excitation function for the Co-59(p, 3n)Ni-57 reaction shows a maximum cross section of 13.8 +/- 1.5 mb at 38 MeV. The optimum energy range for production of Ni-57 was found to be 41 --> 26 MeV resulting in an experimental thick target yield of 19.3 MBq/muAh) (522 muCi/muAh). The level of the Ni-56 impurity is only 0.21% at EOB giving a Ni-57 product of 99.7% radionuclide purity at the time of use (24 h post EOB). Cross section data for the production of Ni-56, Co-56, Co-57, Co-58, Mn-52, Mn-54 and Cr-51 are also presented. A radiochemical procedure, based on cation-exchange chromatography, for the separation of radionickel from an activated cobalt target and other radiochemical and chemical impurities, has been developed. The Ni-57 activity was eluted, using 2 M HCl from a Dowex-50W x 8(H+) column, in a 95% radiochemical yield (15 mL). The Ni-57 has been used to label the anti-cancer drug, doxorubicin, thereby providing the means for pharmacokinetic and pharmacodynamic studies of this compound using positron emission tomography. The labelling has been optimized to give a radiochemical yield of >94%.
引用
收藏
页码:1411 / 1416
页数:6
相关论文
共 18 条
[1]   IRON(III) ADRIAMYCIN AND IRON(III) DAUNORUBICIN COMPLEXES - PHYSICOCHEMICAL CHARACTERISTICS, INTERACTION WITH DNA, AND ANTITUMOR-ACTIVITY [J].
BERALDO, H ;
GARNIERSUILLEROT, A ;
TOSI, L ;
LAVELLE, F .
BIOCHEMISTRY, 1985, 24 (02) :284-289
[2]   METAL ANTHRACYCLINE COMPLEXES AS A NEW CLASS OF ANTHRACYCLINE DERIVATIVES - PD(II)-ADRIAMYCIN AND PD(II)-DAUNORUBICIN COMPLEXES - PHYSICOCHEMICAL CHARACTERISTICS AND ANTITUMOR-ACTIVITY [J].
FIALLO, MML ;
GARNIERSUILLEROT, A .
BIOCHEMISTRY, 1986, 25 (04) :924-930
[3]  
FORD JM, 1990, PHARMACOL REV, V42, P155
[4]   THE BINDING OF COPPER IONS TO DAUNOMYCIN AND ADRIAMYCIN [J].
GREENAWAY, FT ;
DABROWIAK, JC .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1982, 16 (02) :91-107
[6]  
HASKELL CM, 1990, CANCER TREATMENT
[7]  
JANNI JF, 1982, ATOMIC DATA NUCL DAT, V27, P383
[8]   THE INDIRECT PRODUCTION OF NO-CARRIER-ADDED CO-57 VIA THE CO-59 (P,3N) NI-57-]CO-57 REACTION [J].
JOHNSON, PC ;
LAGUNASSOLAR, MC ;
AVILA, MJ .
INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1984, 35 (05) :371-376
[9]  
Lederer C.M., 1978, TABLE ISOTOPES, V7th ed.
[10]  
MEHTA BM, 1992, J NUCL MED, V33, P1373